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The morphometric model is a useful screening test to 
investigate the possibility of OSAS in patients during initial 
office visits. Aim: To evaluate the clinical applicability of the 
Kushida morphometric model in a sample of patients with 
sleep-disordered breathing, and to define a cutoff value to 
differentiate patients with mild, moderate and severe apnea. 
Method: A sample of 80 patients with sleep respisratory 
disorder was studied. Patients were aged between 18 and 75 
years, of both genders and had been submitted previously 
to polysomnography. The model cutoff value to distinguish 
between patients with or without apnea is 70. Results: In 
this sample, the model cutoff value in all four groups was 
less than 70. It was impossible to establish a cutoff value 
according to the gravity of the condition, due to the proximity 
and the nonlinear increase in the values presented by the 
nonapneic group and those with mild and moderate apnea. 
Conclusion: The Kushida morphometric model can be 
applied in clinical practice to a selected sample and it was 
impossible to establish a cutoff value to separate patients 
with obstructive sleep apnea-hypopnea syndrome according 
to severity.
Keywords: obstrutive sleep apnea, mouth, measurements, 
obesity.
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INTRODUCTION
Studies of the main characteristics of patients with 
Sleep Apnea-Hypopnea Syndrome (SAHS) started with 
Burwell, Robin, Waley and Bickelmann (1956)1. They 
described the Pickwickian Syndrome to honor the Eng-
lish novelist Charles Dickens, author of the famous “The 
Posthumous Papers of the Pickwickian Club” (1837), the 
main character of which was an obese, sleepy and snor-
ing boy. The syndrome is classically composed of obesity, 
hypercapnia, cor pulmonale, erythrocytosis and excessive 
daytime sleepiness.
According to the definition published by the Ameri-
can Academy of Sleep Medicine (AASM) during a task 
force launched in 1999, SAHS is characterized by recurring 
episodes of partial or total obstruction of upper airways 
during sleep. It presents as a reduction (hypopnea) or 
cessation (apnea) of air flow, regardless of inspiratory ef-
fort, lasting at least 10 seconds. Hypopnea is defined as a 
more than 50% reduction in respiratory amplitude, or less 
than 50% if associated with oxygen desaturation over 3% 
and/or awakening (AASM Task Force, 1999)2.
In an important epidemiological study, Young, 
Palta, Dempsey, Skatrud, Weber and Badr (1993)3 con-
cluded that SAHS has an increased prevalence in the obese, 
affecting 2% of women and 4% of men if we consider an 
apnea-hypopnea index (AHI) over 5 on polysomnography 
(PSG) and the presence of excessive daytime sleepiness; 
this condition is more frequent in middle-aged persons 
(Olson, King, Hensley and Saunders, 1995)4.
The pathophysiology of SAHS is still not fully under-
stood; it is clear that the main phenomenon of the disease 
is pharyngeal collapse resulting in part from upper airway 
and facial skeletal anatomical alterations and reduced 
neuromuscular tonus (Arens and Marcus, 2004)5.
The main SAHS-related upper airway anatomical 
alterations are: tonsillar hypertrophy, a large tongue, me-
dial tonsillary pillars, a posterior and/or thickened and/or 
a web (a membrane formed by the low insertion of the 
tonsillar pillar posterior to the uvula) soft palate, and a 
long and/or thickened uvula6-9.
Many studies have been done assessing craniofa-
cial dimorphism in SAHS patients using cephalometrics, 
computed tomography, magnetic resonance imaging, and 
acoustic reflection. Although there is controversy in the 
results, craniofacial alterations most closely related to the 
occurrence and severity of SAHS are: retroposition of the 
maxilla, shortening of the mandibular body, inferiorly 
displaced hyoid bone, retrognatism, dental occlusion class 
II (mesial sulcus of the 1st permanent lower molar articu-
lates posteriorly with the mesiovestibular cusp of the 1st 
permanent upper molar) and ogival hard palate5,7-12.
Currently SAHS is considered a chronic, progres-
sive and incapacitating disease with high morbidity and 
mortality, since it is associated with an increased risk of 
cardiovascular diseases, traffic accidents and depression. 
It is considered a public health issue13-16.
PSG is an essential assessment and diagnosis tool 
in Sleep Medicine; however, it is a time-consuming and 
expensive exam requiring expert technicians, which fre-
quently limits its use, with the result that SAHS is underdi-
agnosed. Young, Evans, Finn and Palta (1997)17 estimated 
that 93% of women and 82% of men with moderate or 
severe SAHS are not diagnosed by physicians.
Various investigators have developed predictive 
clinical rules for SAHS using mathematical formulae in-
cluding variables such as the body mass index (BMI), 
the cervical circumference (CC), oxygen saturation, the 
AHI and questionnaires6,7,18-21. However, these models do 
not take into account craniofacial alterations, and some 
authors consider them insufficient22. Kushida, Efron and 
Guilleminault (1997)22 proposed a morphometric model 
(MM) described below, which includes measurements of 
the mouth, the BMI and the CC to predict which patients 
would be at an increased risk for SAHS (and therefore 
would require PSG promptly). This model was applied to 
300 patients (224 men and 76 women) aged between 15 
and 75 years. All of them had undertaken PSG, but the 
examiner did not have access to the results of this exam. 
The criteria for diagnosing SAHS was the presence of 
typical symptoms (snoring, respiratory pauses, excessive 
daytime sleepiness, Epworth’s Sleepiness Scale > 10, and 
an AHI > 5.
 
{P + (Mx - Mn) + 3 x OJ} + 3 x [Max (IMC - 25)] x 
(CC / IMC)
P: palatal height in millimeters
Mx: distance between the mesial side of the upper 
2nd molars in millimeters
Mn: distance between the mesial side of the lower 
inferior 2nd molars in millimeters
OJ: overjet (horizontal distance between the incisor 
side of the upper and lower central incisors)
BMI: weight (kilograms)/height (meter2)
CC: cervical circumference in centimeters
In patients with a BMI ≤ 25 only the first part of the 
formula was applied (between wavy brackets) in such a 
way that the second part of the formula (between brackets) 
was always zero or a positive number.
Following application of the MM, patients were 
divided into two groups: one without SAHS (MM< 70) 
and one with SAHS (MM≥ 70); 46 patients were allocated 
to the first group and 254 to the second group. The MM 
classified six patients with SAHS as non-apneic. Sensitivity 
was 97%, specificity was 100%, the positive predictive value 
was 100%, and the negative predictive value was 88.5%.
The BMI and the CC were also used to divide the 
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patients into both groups, with cutoff points of 25 kg/m2 
(BMI) and 40cm (CC). We compared the individual capa-
bility of the MM, the BMI and the CC to identify patients 
with and without SAHS; the MM was superior, followed 
by the BMI and the CC.
The authors conclude that the MM is a quick and 
safe form of screening patients that will require specialized 
investigation such as PSG to establish the severity of the 
disease and to guide the appropriate treatment.
The aims of this study were to assess the clinical ap-
plicability of the Kushida MM in a sample of patients with 
sleep-related respiratory disorders (SRDs) and to define a 
cutoff point to identify patients with mild, moderate and 
severe apnea.
METHODS
We studied 80 patients from the Sleep Disorders 
Outpatient Clinic of the Otorhinolaryngology (ORL) and 
Head & Neck Surgery (HNS) Unit at the Sleep Institute of 
the Sao Paulo Federal University (UNIFESP) between Sep-
tember 2003 and August 2004. All patients underwent prior 
polysomnography and accepted the free and informed 
consent form proposed. The study was approved by the 
UNIFESP-EPM Research Ethics Committee.
1. Inclusion criteria
• patients complaining of snoring, apnea and/or 
excessive daytime sleepiness
• adults aged between 18 and 75 years
• both genders
• patients having undertaken a prior polysomnog-
raphy.
2. Exclusion criteria
• a history of benign or malignant upper airway 
neoplasms
• patients with limited mouth opening
• absence of upper and/or lower central incisors
• absence of the upper and lower 2nd molars
• patients unable or unwilling to cooperate with 
the study
• prior treatment for SAHS
• the use of illegal drugs, alcohol and hypnotic 
medication.
3. Selection of patients
The 80 patients were selected from the Sleep 
Disorders Outpatient Clinic of the ORL and HNS Unit at 
UNIFESP during consultation with an otorhinolaryngolo-
gist or when undergoing PSG. There were 20 patients with 
mild SAHS (5>AHI≤15), 20 patients with moderate SAHS 
(15>AHI≤30), 20 patients with severe SAHS (AHI >30 and 
20 patients with a normal AHI (AHI≤5).
4. Polysomnography
Polysomnography was an overnight recording of 
the patients sleep with monitoring by an electroencepha-
logram (EEG), an electrooculogram (EOG), a tibialis and 
mentalis electromyogram (EMG), an electrocardiogram 
(ECG), measurement of airflow through a nasal cannula 
and an oral thermistor, breathing movements measured 
by thoracoabdominal belt, oxymetry for SaO2, and micro-
phone recordings of snoring. We used the SAC-Oxford, 
version 10.0 polysomnograph.
EEG, EOG and EMG interpretation defined sleep 
architecture stages according to the criteria proposed by 
Rechtschtaffen and Kales (1968).
The staging of respiratory events followed the crite-
ria proposed by the AASM (AASM Task Force, 1999).
5. Assessment of patients
After selection, age, gender, weight, height, and 
frequency of snoring (nightly, nearly every night, occa-
sionally or never) were recorded. Patients with an AHI ≤ 
5, but which reported snoring every night or nearly every 
night, were classified as snorers. Patients that snored oc-
casionally or never were classified as non-snorers if PSG 
recorded intermittent snoring; if PSG recorded constant 
snoring, these patients were classified as snorers.
Next, Kushida’s MM was applied. Patients were 
placed in the Frankfurt position and standard tools were 
used; all measurements were made by the same exam-
iner. Measurements of the mouth, except for overjet (OJ), 
were made with the tongue in a relaxed position and the 
mouth open at a 20o angle with the mandibular condyle. 
A compass with a fixed 20o angle was placed over the 
temporomandibular joint; the tip of the upper leg was 
aligned with the upper central incisors and the tip of the 
lower leg was aligned with the lower central incisors, thus 
obtaining the desired mouth opening. A second compass 
was used to obtain the mouth measurements (the maxilla 
intermolar distance - Mx, the mandible intermolar distance 
- Mn and the palatal height - P), which were then trans-
posed to a ruler. A 40 millimeter (mm) ruler was used to 
measure the OJ, and a tape measure was placed over the 
cricothyroid membrane to measure the CC.
6. Forms of assessing the results
Variables were expressed as the average, the stan-
dard deviation, and minimum and maximum values, which 
showed a normal distribution.
ANOVA was used for comparison between groups; 
Ducan’s post-test was used if needed to separate the 
groups.
The Student’s T test for independent samples was 
used for comparisons between two groups.
Peason’s test was used to assess correlations be-
tween variables.
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The multivariate regression analysis was used to 
assess factors that could define the weighting of some 
measurements.
RESULTS
Ages and the BMI of the 80 patients are shown on 
Table 1. There were more men than women (54 men/26 
women); the average age was 40.5 ± 13.6 years, and on 
average the patients were slightly overweight.
Data on orofacial and CC measurements and final 
MM values of the 80 patients are on Table 2.
A comparison between the averages of all variables 
for the four groups in this study is shown on Table 3. The 
following variables were significant in the comparison of 
the four groups of patients (p ≤ 0.05): age, BMI, E1 and 
2, SaO2 min, OJ, CC and MM. The following variables 
were not significant (p > 0.05): ES, E3 and 4, REM, P, Mx 
and Mn.
Variables were compared according to gender and 
whether snoring was present or absent; differences are 
shown on Tables 4 and 5. Variables that were statistically 
Table 1. Age and BMI of the 80 patients.
Variables Age (years) BMI (Kg/m2)
Average 40,5 27,4
Standard Deviation 13,6 4,9
Minimum Value 18,0 17,0
Maximum Value 71,0 45,0
BMI: body mass index
Table 3. Average and standard deviation of variables in subgroups.
Variables Non-apneic SD Mild SAHS SD Moderate SAHS SD Severe SAHS SD p
n=20 n=20 n=20 n=20
Age (years) 35,2 13,3 37,9 15,9* 47,2 11,9●* 41,2 10,6 0,027
Gender (M/F) 5/15  15/5  18/2  16/4   
BMI 25,5 5,7□ 25,5 2,7□ 27,3 3,2* 31,4 5*□ 0,0001
ES 81,5 11,3 80,7 12,8 82,6 14 83,2 9,9 0,920
E1 e 2 63,4 7,5□ 62,9 10□ 65,5 8,7□ 78,3 9,2□ 0,000001
E3 e 4 20,3 6,4 19,4 8,7 15,2 7,17 21,6 24,7 0,506
REM 16,7 6,6 17,9 5,9 19,7 6,2 16,7 6,8 0,132
SaO2 min 89,6 2,9□ 86,3 5□ 77,9 8,8 67,2 10,8□ 0,000000
P 31,6 7,1 31 5,6 33,3 4,3 29,2 7,5 0,230
Mx 39,2 4,6 36,3 4,4 36,7 4,8 36,6 4 0,152
Mn 34,8 8,5 36,7 5 37,9 5,1 36,2 5,1● 0,444
OJ 2,9 1,3 3,7 2,1 2,61 1,8 3,6 4,4 0,41
CC 36,7 3,7*□ 40,3 3,1* 41,2 2,2● □ 43,6 3,9● * 0,000000
MM 52,4 14,5 50,3 17* 51,7 14,7● 66,7 22,3● * 0,013
Analysis of Variance ANOVA; Duncan’s Post-Test
● p<0.05 REM: REM sleep as a percentage
* p<0.01 SaO2 min: minimum oxyhemoglobin saturation as a percentage
□ p<0.001 AHI: apnea-hypopnea index per hour of sleep
n: number of patients; P: palatal height in millimeters
DP: standard deviation Mx: distance between the mesial side of the upper 2nd molars millimeters
M: male; Mn: distance between the mesial side of the lower 2nd molars millimeters
F: female; OJ: overjet in millimeters
SAHS: obstructive sleep apnea-hypopnea syndrome; CC: cervical circumference in centimeter
BMI: body mass index in Kg/m2; MM: morphometric model values
ES: sleep efficiency as a percentage
E1 and 2: sum of NREM sleep stages 1 and 2 as a percentage
E3 and 4: sum of NREM sleep stages 3 and 4 as a percentage
Table 2. Orofacial and Cervical Circumference Measurements and 
Morphometric Model Values of the 80 patients.
Variables P Mx Mn OJ CC MM
Average 31,3 37,2 36,4 3,23 40,4 55,1
Standard Deviation 6,3 4,5 6,1 2,65 4,1 18,1
Minimum Value 20,0 27,0 4,0 0,0 31,0 26,0
Maximum Value 48,0 51,0 46,0 20,0 54,0 115,5
P: palatal height in millimeters
Mx: distance between the mesial side of the upper 2nd molars milli-
meters
Mn: distance between the mesial side of the lower 2nd molars milli-
meters
OJ: overjet in millimeters
CC: cervical circumference in centimeters
MM: morphometric model values
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significant regarding gender were: AHI, SaO2 min, Mn 
and CC. Similar results regarding snoring were: age, BMI, 
SaO2 min, AHI and CC.
When correlating the AHI with the BMI, P, Mx, Mn, 
OJ, CC and MM, statistically significant variables (p ≤ 0.05) 
were: BMI, CC and MM (Figures 1, 2 and 3). Statistically 
significant variables were the same for SaO2 min (p ≤ 
0.05) (Figures 4, 5 and 6).
The AHI, the SaO2 min, and other variables were 
analyzed by multivariate linear regression. The CC was sig-
nificant among them to establish the AHI(p = 0.03). The Mx 
was significant (p = 0.016) to establish the SaO2 min.
DISCUSSION
The average age of the patients was 40.5 ± 13.6 
years, being higher in the moderate SAHS group. This is 
similar to reports in literature showing a higher prevalence 
of the disease between ages 40 and 60. There was a statisti-
Table 4. Average of variables according to gender.
Variables
Gender
pMale
(n=54/67,5%)
SD
Female
(n=26/32,5%)
SD
AHI 29,4 27,1 13,3 21,3 0,008 *
SaO2
mín
78,1 11,4 84,7 9,8 0,013 *
Mn 37,5 5,1 34,4 7,3 0,035 *
CC 41,9 2,6 37,5 4,8 0,000001*
* Significant findings by the chi-squares test (p<0.05)
n: number of patients
AHI: apnea-hypopnea index by hours of sleep
SaO2 min: minimum oxyhemoglobin saturation as a percentage
Mn: distance between the mesial side of lower 2nd molars in milli-
meters
CC: cervical circumference in centimeters
Table 5. Average of variables according to snoring.
Variables
Snoring
pPresent
(n=74 /92,5%)
DP
Absent
(n=6 /7,5%)
DP
Idade 41,4 13,6 28,3 6,1 0,02 *
IMC 27,8 4,7 21,8 1,9 0,003 *
SaO2 
mín
79,5 11,3 90,8 3,9 0,017 *
IAH 25,7 26,6 2,7 4,1 0,038 *
CC 40,9 3,7 34,5 3,5 0,0001 *
* Significant findings by the chi-squares test (p<0.05)
n: number of patients
BMI: body mass index
SaO2 min: minimum oxyhemoglobin saturation as a percentage
AHI: apnea-hypopnea index by hours of sleep
CC: cervical circumference in centimeters
cally significant difference between the ages of moderate 
SAHS patients compared to the non-apneic and mild SAHS 
groups, confirming the increased severity of the disease 
with age. This is a result of increased muscle flaccidity 
associated with decreased neuromuscular tonus, making 
the pharynx prone to collapse and apnea3,4,22.
Figure 1. AHI x BMI - AHI: apnea-hypopnea index; BMI: body mass 
index
Figure 2. AHI x CC - AHI: apnea-hypopnea index; CC: cervical cir-
cumference
Figure 3. AHI x MM - AHI: apnea-hypopnea index; MM: morphometric 
model
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Figure 4. SaO2min x BMI - SaO2min: minimum oxyhemoglobin satu-
ration; BMI: body mass index
Figure 5. SaO2min x CC - SaO2min: minimum oxyhemoglobin satu-
ration; CC: cervical circumference
Figure 6. SaO2min x MM - SaO2min: minimum oxyhemoglobin satu-
ration; MM: morphometric model
there were more men only in the apnea groups; this is 
similar to published papers that reveal a greater prevalence 
of the disease in men3,4.
The average BMI was 27.4 ± 4.9 kg/m2, character-
izing the group as overweight (BMI between 25 and 29.9 
kg/m2) according to the World Health Organization (1998). 
The severe SAHS group had statistically significant differ-
ences compared to the moderate and mild SAHS groups 
and the non-apneic group, demonstrating that the BMI is 
related to the occurrence and severity of the disease3,6,8.
There was a statistically significant difference be-
tween groups in the SaO2 min parameters measured dur-
ing polysomnography. The pharynx in the SAHS tends to 
collapse more easily, leading to reduced air flow and a 
lower SaO2 min; thus, disease severity is proportional to 
oxyhemoglobin desaturation.
SAHS increases sleep stages 1 and 2, and reduces 
sleep stages 3 and 4 and REM sleep, as seen on Table 3. 
However there was a statistically significant difference 
between groups only in stages 1 and 2.
The percentage of slow-wave sleep falls gradually 
from age 20 onwards. This might explain why the moder-
ate SAHS, which had a higher average age, had a lower 
percentage of stages 3 and 4.
There was no statistically significant difference in 
mouth measurements between our four groups. Mouth 
measurements (P, Mx and Mn) has lower average values 
compared to those described by Kushida, Efron and Guil-
leminault (1997)22. In their study, these authors found a 
statistically significant difference between patients with 
and without SAHS. These measurements are strongly 
related to genetic factors and/or to oral breathing. The 
populations under study in our groups and in Kushida, 
Efron and Guilleminault’s study belong to different origins 
(Latin and North-Americans), there was no standardization 
to account for ethnicity, and some of our patients came 
from the Sleep Disorders Outpatient Clinic of the ORL Unit 
(which might have led to the selection of a higher number 
of oral breathers). These facts may explain the differences 
between both studies.
According to findings by Kushida, Efron and Guil-
leminault (1997)22, and Schellenberg, Maislin and Schwab 
(2000)8, there was a statistically significant difference in 
measurements of the overjet between subgroups in our 
sample.
The average cervical circumference was 40.4 ± 4.1 
cm, and there was a statistically significant difference be-
tween the subgroups, with increasing values according to 
the severity of the obstructive respiratory sleep disorder, 
confirming published findings that correlate the CC with 
the occurrence and severity of SAHS19. Kushida, Efron and 
Guilleminault (1997)22 established a cutoff point of 40 cm 
in CC to separate patients with and without SAHS. In our 
study the average CC in non-apneic patients was 36.7cm 
There were more men than women in an approxi-
mately 2:1 proportion. Looking at the groups separately, 
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(31 to 43cm) and the average CC for SAHS patients was 
over 40cm, a statistically significant difference coincid-
ing with the values published by the abovementioned 
authors.
In our study the MM cutoff point was 70. The val-
ues we found were below 70, however the severe SAHS 
group came closest to this number (66.7 average), a statisti-
cally significant difference compared to the other groups. 
Although there was a significant difference between the 
subgroups, we were unable to establish a cutoff point ac-
cording to disease severity, as the values were very similar 
and did not increase linearly from the non-apneic to the 
mild and moderate SAHS groups. On the other hand, 
the authors of the MM state in their paper that, similar to 
other predictive models, the MM is useful to screen and 
identify the more severe cases; these patients may then 
be prioritized for treatment. Furthermore, the authors also 
underline the importance of PSG as an adequate tool for 
diagnosis and eventual treatment.
Variables that showed differences when compared 
according to gender were the AHI, the SaO2 min, the 
CC and the Mn, all of them indicating increased severity 
in men. The male gender is an important risk factor for 
the occurrence and severity of SAHS2,3,8. Thus one would 
expect that disease-related variables such as the AHI, the 
SaO2 min and the CC would have statistically significant 
values. Furthermore, men tend to accumulate fat in the 
neck, and the CC provides a better correlation with the 
presence of SAHS than the body weight19. The only mouth 
measurement that was different between men and women 
was the Mn (37.5 ± 5.1 cm in men and 34.4 ± 7.3 cm in 
women). After the paper on which our study is based was 
published, and until our last bibliographical survey, there 
was no publication reproducing the MM, which restricts 
comparisons of our data. New studies are needed on this 
theme so that we may assess the correlation between the 
new proposed measurements (P, Mx and Mn) and obstruc-
tive respiratory sleep disorders.
92.5% of patients complained of snoring. Such a 
high prevalence may be explained by the fact that this is 
a selected population with obstructive respiratory sleep 
disorders. Comparing variables according to the presence 
or absence of snoring, we observed that age, BMI, SaO2 
min, AHI and CC had statistically significant differences 
in both groups, with increased severity in patients with 
a complaint of snoring. This is expected, as emphasized 
above concerning the importance of each of these vari-
ables in SRD.
Separately correlating the AHI and the SaO2 min 
with the BMI, P, Mx, Mn, OJ, CC and the MM, we found that 
the statistically significant variables were the BMI, the CC 
and the MM, for both analyses. The AHI and the SaO2 min 
are strongly linked to SAHS. The variables that best corre-
late with obstructive respiratory sleep disorders according 
to medical literature are the BMI and the CC7,11,18,19,21. Our 
results confirm findings published by these articles.
Individually, measurements of the mouth (P, Mx, 
Mn and OJ) have no statistically significant correlation with 
the AHI and the SaO2 min; however, when grouped in 
the MM, this method shows a strong positive correlation. 
Calculations in the MM includes measurements of the 
mouth, the CC and the BMI, which may justify the results 
and underline the interaction between factors involved in 
the pathophysiology of SAHS.
Multivariate linear regression analysis revealed that 
the CC was significant to establish the AHI. This finding, 
together with the fact that the CC was the only measure-
ment which increased proportionally to the severity of the 
disease (with a statistically significant difference between 
all groups), and which correlated with the AHI and the 
SaO2 min, supports the importance of the relationship 
between the CC and SAHS, as described previously.
A similar analysis using the SaO2 min showed that 
the Mx is the most significant measurement. The paucity 
of studies on direct measurements of the facial skeleton 
hinders comparisons with findings in literature, but un-
derlines the value of craniofacial dimorphism in SAHS, as 
shown in numerous papers5,7-12.
CONCLUSION
1. The morphometric model proposed by Kushida, 
Efron and Guilleminault is applicable to the selected 
sample in clinical practice.
2. It was not possible to establish a cutoff point to 
classify patients with sleep apnea-hypopnea syndrome 
according to severity.
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